Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Member Meetup

PSA's 2025 Recap: Major "Firsts," Movement-Altering Exposés, Psychedelic Community Building, and more!

PSA's 2025 Recap: Major "Firsts," Movement-Altering Exposés, Psychedelic Community Building, and more!

Recapping a Banner Year for the Psychedelic Beat

PSA’s 2025 Recap:

Major "Firsts," Movement-Altering Exposés, Psychedelic Community Building, and more!

Support independent journalism

The PSA Media Fund

Psychedelic State(s) of America isn’t another news outlet — it’s a vessel to help the fantastic independent psychedelic and cannabis media organizations that already exist do more of what they do best. Our coverage is reader-funded, and your support keeps news, commentary, and education on psychedelic policy free for everyone.

Donate to PSA

Until next time,
The Psychedelic State(s) of America Team

Hosted with: PSA Media Team, Jack Gorsline